Memory impairment, executive dysfunction, and intellectual decline in preclinical Alzheimer's disease.
about
Semi-supervised cluster analysis of imaging dataChocolate, Air Pollution and Children's Neuroprotection: What Cognition Tools should be at Hand to Evaluate Interventions?Amyloid positron emission tomography and cognitive reserveBilingualism and Cognitive Reserve: A Critical Overview and a Plea for Methodological InnovationsThe relevance of beta-amyloid on markers of Alzheimer's disease in clinically normal individuals and factors that influence these associationsThe Alzheimer's prevention initiative composite cognitive test score: sample size estimates for the evaluation of preclinical Alzheimer's disease treatments in presenilin 1 E280A mutation carriersAt the interface of sensory and motor dysfunctions and Alzheimer's disease.Longitudinal imaging pattern analysis (SPARE-CD index) detects early structural and functional changes before cognitive decline in healthy older adultsThe relation between instrumental musical activity and cognitive agingHearing loss and cognition in the Baltimore Longitudinal Study of Aging.Alzheimer brain-derived amyloid β-protein impairs synaptic remodeling and memory consolidation.Perturbations of neural circuitry in aging, mild cognitive impairment, and Alzheimer's disease.Quantile regression with a change-point model for longitudinal data: An application to the study of cognitive changes in preclinical alzheimer's disease.Patterns of brain atrophy associated with episodic memory and semantic fluency decline in aging.The Studying Multiple Outcomes After Aural Rehabilitative Treatment Study: Study Design and Baseline Results.Longitudinal trajectories of everyday function by diagnostic status.Cross-Sectional and Longitudinal Effects of CREB1 Genotypes on Individual Differences in Memory and Executive Function: Findings from the BLSAThe A4 study: stopping AD before symptoms begin?Building a pipeline to discover and validate novel therapeutic targets and lead compounds for Alzheimer's disease.Brain substrates of learning and retention in mild cognitive impairment diagnosis and progression to Alzheimer's diseaseAPOE epsilon4 genotype and longitudinal changes in cerebral blood flow in normal aging.IDE (rs6583817) polymorphism and pulse pressure are independently and interactively associated with level and change in executive function in older adults.Group-Level Progressive Alterations in Brain Connectivity Patterns Revealed by Diffusion-Tensor Brain Networks across Severity Stages in Alzheimer's Disease.Lexical retrieval in discourse: an early indicator of Alzheimer's dementia.Development of a psychometrically equivalent short form of the Face-Name Associative Memory Exam for use along the early Alzheimer's disease trajectoryChanges in cognition.Free and cued selective reminding identifies very mild dementia in primary care.Neurodegenerative basis of age-related cognitive decline.JointMMCC: joint maximum-margin classification and clustering of imaging data.The Extension of the German CERAD Neuropsychological Assessment Battery with Tests Assessing Subcortical, Executive and Frontal Functions Improves Accuracy in Dementia Diagnosis.An empirically derived composite cognitive test score with improved power to track and evaluate treatments for preclinical Alzheimer's disease.Poor decision making is a consequence of cognitive decline among older persons without Alzheimer's disease or mild cognitive impairment.The benefits of endurance exercise and Tai Chi Chuan for the task-switching aspect of executive function in older adults: an ERP studyThe preclinical Alzheimer cognitive composite: measuring amyloid-related declineBiomarkers and cognitive endpoints to optimize trials in Alzheimer's disease.Brain imaging of nicotinic receptors in Alzheimer's disease.Loss of basic lexical knowledge in old ageTrajectories of Alzheimer disease-related cognitive measures in a longitudinal sample.The free and cued selective reminding test distinguishes frontotemporal dementia from Alzheimer's diseaseThe fate of the 0.5s: predictors of 2-year outcome in mild cognitive impairment.
P2860
Q24623229-1B32531F-DE9A-41FC-B9AF-5449502DABF8Q26738827-9E6A2903-C94B-4C9D-9778-87A2DCB78A71Q26769755-2014E785-5259-47D3-BF57-893FCE865A8FQ26770439-CADB03D7-3E16-4E13-A28A-447F51F6F33BQ26830467-027A9DB7-168E-40D3-84BD-70981B63FD77Q26849380-3336DD88-3617-45AB-AA78-48FF205ED637Q27000410-91DD7BBF-A515-4D30-9B1A-060E85BE5421Q28260610-9C4EA0C1-1A05-4374-9695-F96FD5F32A4CQ28308190-76EFB992-82BF-4B94-8EFA-D06D3738FD83Q30461941-AAD8A581-7934-4D5F-B677-00FBF7D1250CQ30535426-ABC631D9-890E-4605-828A-AA72C500CA52Q30586952-1C7119F8-7482-4386-83F7-82A80F91A7FEQ30936791-21EBCCFD-A8ED-4CD2-BE8A-B48C5ACD319DQ33563577-86D66B50-24AB-458A-ACDA-459B64498642Q33606491-D208E4BD-7E62-4547-9FC0-16988B3D4324Q33614486-A364DCF0-F7B3-4BB6-BE3C-F2655EFF483FQ33689729-E38BB340-9B2A-49F6-8400-B4CC6AE07844Q33725775-D3B2ED34-FF7F-4A44-BF88-9A4657D3CD92Q33745617-C7610BE7-803D-4AB9-A358-6B9194930F68Q33776799-E5BA82E4-8456-41C2-9C70-9B8D9F83BD0FQ33796980-6F7703C1-4CE9-4395-A225-EAE22D836F4DQ33801010-470BFC35-EC48-4F03-A133-87B194425699Q33881832-4E460754-AC15-433B-8DCA-DF502712725FQ33893311-E7C080D9-A9AA-490F-81B5-63CEC58B8672Q34051576-91ED0505-30E3-4D79-8C50-028FB52278DCQ34073106-84AB26F2-2792-4F28-BBA3-0DB1CD7481DBQ34088606-78483561-8A35-40EC-89D1-2366360D9CA0Q34140396-F5FDB6CE-E19F-4D41-9DA6-F0FA1F411CCCQ34157017-693E0103-D199-4AED-BC22-BE1AF6DA6723Q34250070-D4E7AF10-5BCE-46CE-BB49-B585FA8B9883Q34364368-BD16524A-85BD-42B4-8B38-61C665427AFDQ34391756-E1E2B6F3-1915-4312-BBBC-5C4A9F7D09F8Q34413582-B7E078D7-884F-49D2-984F-970EF48A4DDBQ34422469-115DDFF6-0CFE-4D59-84B6-08B706A77467Q34477459-5EF578A0-11C7-44A4-BCF3-57DF6C8E44F5Q34496928-4A445EFB-BD51-4F1B-8EA8-E48FC421797AQ34552357-F73049BF-84A1-4070-8FFF-AC5FDA2F1496Q34618639-355223AF-1F56-4496-B369-0B92510500B8Q34683582-C515FF8B-21F5-4C83-AF66-E6EB36E63C96Q34807653-C5582AE5-05F3-46C5-855C-5681608796FE
P2860
Memory impairment, executive dysfunction, and intellectual decline in preclinical Alzheimer's disease.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on March 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Memory impairment, executive d ...... eclinical Alzheimer's disease.
@en
Memory impairment, executive d ...... eclinical Alzheimer's disease.
@nl
type
label
Memory impairment, executive d ...... eclinical Alzheimer's disease.
@en
Memory impairment, executive d ...... eclinical Alzheimer's disease.
@nl
prefLabel
Memory impairment, executive d ...... eclinical Alzheimer's disease.
@en
Memory impairment, executive d ...... eclinical Alzheimer's disease.
@nl
P2093
P2860
P1476
Memory impairment, executive d ...... eclinical Alzheimer's disease.
@en
P2093
Charles B Hall
Claudia Kawas
Ellen Grober
Susan M Resnick
P2860
P304
P356
10.1017/S1355617708080302
P577
2008-03-01T00:00:00Z